Virtually all federal agencies are now focusing on the regulatory implications of nanotechnologies. B&C offers an experienced group of professionals with unique skills, capabilities, and strong relationships with the U.S. Environmental Protection Agency (EPA), the National Institute for Occupational Safety and Health (NIOSH), the Occupational Safety and Health Administration (OSHA), and Food and Drug Administration (FDA) decision-makers, all of which are essential for the chemical community to navigate around the challenges and benefits posed by current uses of engineered nanoscale materials and the emerging commercialization of nanotechnologies.
B&C has made a concerted effort to be in the forefront of the science policy debate involving nanotechnologies and other emerging technologies. Lynn Bergeson served in 2004 and 2005 on the American National Standards Institute (ANSI) Nanotechnology Standards Panel (NSP) Steering Committee and is now a member of the ISO Technical Committee 229 on Nanotechnologies, which is seeking to coordinate the development of voluntary consensus standards relating to various aspects of nanotechnologies. Ms. Bergeson also serves on the President’s Council of Advisors on Science and Technology (PCAST) Nanotechnology Technical Advisory Group (PCAST nTAG). She serves on EPA’s Steering Committee for the Pollution Prevention Through Nanotechnology Conference. She is a member of the Converging Technologies Bar Association (CTBA), Board of Directors and Chair of the CTBA Environmental, Health, and Safety Committee. Ms. Bergeson also serves as counsel to the American Chemistry Council Nanotechnology Panel, which consists of companies engaged in various applications of nanotechnologies and/or engineered nanoscale materials.
More information is available regarding B&C’s Nanotechnology Practice, as well as its other areas of expertise listed below: